RNA-Seq and ChIP-Seq Reveal SQSTM1/p62 as a Key Mediator of JunB Suppression of NF-κB-Dependent Inflammation

Journal of Investigative Dermatology

Volumn 135, Issue 4, 2015, Pages 1016-1024

  Zhang, Xiaoling ^a   Jin, Jane Y ^a   Wu, Joseph ^a   Qin, Xiaoxia ^b   Streilein, Robert ^a   Hall, Russell P ^a   Zhang, Jennifer Y ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6 RECEPTOR; MATRILYSIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P62; PYRROLIDINE DITHIOCARBAMATE; SQSTM1 PROTEIN; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSCRIPTION FACTOR JUNB; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CCL2 PROTEIN, MOUSE; CXCL10 PROTEIN, MOUSE; CYTOKINE; HEAT SHOCK PROTEIN; JUNB PROTEIN, MOUSE; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SQSTM1 PROTEIN, MOUSE; THIOCARBAMIC ACID DERIVATIVE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL GROWTH; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME 5; CONTROLLED STUDY; DELETION MUTANT; ELECTRIC RESISTANCE; ENZYME ACTIVATION; ENZYME INHIBITION; GENE CONTROL; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; KERATINOCYTE; LOSS OF FUNCTION MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PSORIASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; TRANSCRIPTION INITIATION SITE; UPREGULATION; WESTERN BLOTTING; ANIMAL; CHEMISTRY; CYTOLOGY; DNA MICROARRAY; EPIDERMIS; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; GENE DELETION; GENETICS; HEK293 CELL LINE; INFLAMMATION; METABOLISM; MUTATION; REGENERATION; REPORTER GENE; SEQUENCE ANALYSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL ADHESION; CELL PROLIFERATION; CHEMOKINE CCL2; CHEMOKINE CXCL10; CHROMATIN IMMUNOPRECIPITATION; CYTOKINES; EPIDERMIS; GENE DELETION; GENES, REPORTER; HEAT-SHOCK PROTEINS; HEK293 CELLS; HUMANS; INFLAMMATION; KERATINOCYTES; MICE; MUTATION; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PYRROLIDINES; REGENERATION; SEQUENCE ANALYSIS, RNA; SKIN PHYSIOLOGICAL PHENOMENA; THIOCARBAMATES; TRANSCRIPTION FACTORS;

EID: 84925447641     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.519     Document Type: Article

References (50)

1. Adler AS, Sinha S, Kawahara TL et al. (2007) Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev 21:3244-57
2. Antonelli A, Fallahi P, Delle Sedie A et al. (2009) High values of Th1 (CXCL10) and Th2 (CCL2) chemokines in patients with psoriatic arthtritis. Clin Exp Rheumatol 27:22-7
3. Belge K, Bruck J, Ghoreschi K (2014) Advances in treating psoriasis. F1000Prime Rep 6:4
4. Chang MA, Morgado M, Warren CR et al. (2014) p62/SQSTM1 is required for cell survival of apoptosis-resistant bone metastatic prostate cancer cell lines. Prostate 74:149-63
5. Clark RA (2010) Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol 130:362-70
6. Dajee M, Lazarov M, Zhang JY et al. (2003) NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421:639-43
7. Danik JS, Pare G, Chasman DI et al. (2009) Novel loci, including those related to crohn disease, psoriasis, and inflammation, identified in a Genomewide association study of fibrinogen in 17 686 women the Women's Genome Health Study. Circ Cardiovasc Genet 2:134-41
8. Detmar M, Orfanos CE (1990) Tumor necrosis factor-alpha inhibits cell proliferation and induces class II antigens and cell adhesion molecules in cultured normal human keratinocytes in vitro. Arch Dermatol Res 282:238-45
9. FanW, Tang Z, Chen D et al. (2010) Keap1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy. Autophagy 6:614-21
10. Fraticelli P, Sironi M, Bianchi G et al. (2001) Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest 107:1173-81
11. Giannopoulou EG, Elemento O (2011) An integrated ChIP-seq analysis platform with customizable workflows. BMC Bioinformatics 12:277
12. Guo C, Chang CC, Wortham M et al. (2012) Global identification of MLL2-targeted loci reveals MLL2's role in diverse signaling pathways. Proc Natl Acad Sci USA 109:17603-8
13. Haider AS, Duculan J, Whynot JA et al. (2006) Increased JunB mRNA and protein expression in psoriasis vulgaris lesions. J Invest Dermatol 126:912-4
14. Helmick CG, Lee-Han H, Hirsch SC et al. (2014) Prevalence of psoriasis among adults in the U.S.: 2003-2006 and 2009-2010 National Health and Nutrition Examination Surveys. Am J Prev Med 47:37-45
15. Huffmeier U, Lascorz J, Becker T et al. (2009) Characterization of psoriasis susceptibility locus 6 (PSORS6) in patients with early onset psoriasis and evidence for interaction with PSORS1. J Med Genet 46:736-44
16. Inoue D, Suzuki T, Mitsuishi Y et al. (2012) Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci 103:760-6
17. Inui T, Chano T, Takikita-Suzuki M et al. (2013) Association of p62/SQSTM1 Excess and Oral Carcinogenesis. PLoS One 8:e74398
18. Jin JY, Ke H, Hall RP et al. (2011) c-Jun promotes whereas JunB inhibits epidermal neoplasia. J Invest Dermatol 131:1149-58
19. Johansen C, Kragballe K, Rasmussen M et al. (2004) Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin. Brit J Dermatol 151:600-7
20. Kent WJ, Sugnet CW, Furey TS et al. (2002) The human genome browser at UCSC. Genome Res 12:996-1006
21. Kulski JK, Kenworthy W, Bellgard M et al. (2005) Gene expression profiling of Japanese psoriatic skin reveals an increased activity in molecular stress and immune response signals. J Mol Med 83:964-75
22. Kuo WL, Sharifi MN, Lingen MW et al. (2014) p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors. PLoS One 9:e90171
23. Lee HM, Shin DM, Yuk JM et al. (2011) Autophagy negatively regulates keratinocyte inflammatory responses via scaffolding protein p62/SQSTM1. J Immunol 186:1248-58
24. Li B, Tsoi LC, Swindell WR et al. (2014) Transcriptome analysis of psoriasis in a large case-control sample: RNA-Seq provides insights into disease mechanisms. J Invest Dermatol 134:1828-38
25. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754-60
26. Li LJ, Shen C, Nakamura E et al. (2013) SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer. Cancer Cell 24:738-50
27. Ling J, Kang Y, Zhao R et al. (2012) KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell 21:105-20
28. Martin M (2011) Cut adapt removes adapter sequences from high-throughput sequencing reads. EMBnet 17:10-2
29. Mathelier A, Wasserman WW (2013) The next generation of transcription factor binding site prediction. PloS Comput Biol 9:e1003214
30. Meixner A, Zenz R, Schonthaler HB et al. (2008) Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formation. Nat Cell Biol 10:1003-11
31. Park CC, Kim KJ, Woo SY et al. (2009) Comparison of the expression profile of JunB, c-Jun, and S100A8 (Calgranulin A) in Psoriasis Vulgaris and Guttate Psoriasis. Ann Dermatol 21:35-8
32. Parkhitko A, Myachina F, Morrison TA et al. (2011) Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent. Pro Natl Acad Sci USA 108:12455-60
33. Paukkonen K, Naukkarinen A, Horsmanheimo M (1995) The development of manifest psoriatic lesions is linked with the appearance of ICAM-1 positivity on keratinocytes. Arch Dermatol Res 287:165-70
34. Plant D, Young HS, Watson RE et al. (2006) The CX3CL1-CX3CR1 system and psoriasis. Exp Dermatol 15:900-3
35. Rachakonda TD, Schupp CW, Armstrong AW (2014) Psoriasis prevalence among adults in the United States. J Am Acad Dermatol 70:512-6
36. Rea SL, Majcher V, Searle MS et al. (2014) SQSTM1 mutations - bridging Paget disease of bone and ALS/FTLD. Exp Cell Res 325:27-37
37. Sanz L, Diaz-Meco MT, Nakano H et al. (2000) The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. EMBO J 19:1576-86
38. Sumigray KD, Foote HP, Lechler T (2012) Noncentrosomal microtubules and type II myosins potentiate epidermal cell adhesion and barrier formation. J Cell Biol 199:513-25
39. Sundaram K, Shanmugarajan S, Rao DS et al. (2011) Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone. Endocrinology 152:4180-9
40. Trapnell C, Hendrickson DG, Sauvageau M et al. (2013) Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol 31:46-53
41. Trapnell C, Pachter L, Salzberg SL (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105-11
42. Wang J, Duncan D, Shi Z et al. (2013) WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res 41:W77-83
43. Wooten MW, Geetha T, Seibenhener ML et al. (2005) The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination. J Biol Chem 280:35625-9
44. Wullaert A, Bonnet MC, Pasparakis M (2011) NF-kappaB in the regulation of epithelial homeostasis and inflammation. Cell Res 21:146-58
45. Yoshihara N, Takagi A, Ueno T et al. (2014) Inverse correlation between microtubule-associated protein 1A/1B-light chain 3 and p62/sequesto-some-1 expression in the progression of cutaneous squamous cell carcinoma. J Dermatol 41:311-5
46. Zenz R, Eferl R, Kenner L et al. (2005) Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437:369-75
47. Zhang B, Kirov S, Snoddy J (2005a) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33:W741-8
48. Zhang JY, Green CL, Tao S et al. (2004) NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK. Genes Dev 18:17-22
49. Zhang JY, Tao S, Kimmel R et al. (2005b) CDK4 regulation by TNFR1 and JNK is required for NF-kappaB-mediated epidermal growth control. J Cell Biol 168:561-6
50. Zotti T, Scudiero I, Settembre P et al. (2014) TRAF6-mediated ubiquitination of NEMO requires p62/sequestosome-1. Mol Immunol 58:27-31